Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,666
2025-08-06 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott P - Purchase D 5.6161 20,000
2025-08-06 NEO / NeoGenomics, Inc. 4 Zook Anthony P. P - Purchase D 5.584 17,900
2025-08-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -14
2025-06-01 NEO / NeoGenomics, Inc. 4 Zook Anthony P. M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 Williams Felicia M - Exercise D 7,160
2025-06-01 NEO / NeoGenomics, Inc. 4 Perez David Brian M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 Floegel Elizabeth M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4/A HANNAH ALISON L. M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 Kelly Michael Aaron M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 KANOVSKY STEPHEN M M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 Gunn Neil M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 TETRAULT LYNN A. M - Exercise D 12,254
2025-06-01 NEO / NeoGenomics, Inc. 4 Zook Anthony P. F - Taxes D -3,424
2025-06-01 NEO / NeoGenomics, Inc. 4 HANNAH ALISON L. A - Award D 12,254
2025-05-27 NEO / NeoGenomics, Inc. 4 Kelly Michael Aaron M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016 P - Purchase I 7.60 5,000
2025-05-12 NEO / NeoGenomics, Inc. 4 Stone Warren P - Purchase D 8.578 5,700
2025-05-11 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 9,613
2025-05-11 NEO / NeoGenomics, Inc. 4 Olivo Alicia C M - Exercise D 6,503
2025-05-11 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott M - Exercise D 13,005
2025-05-11 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,584
2025-05-11 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -3,167
2025-05-11 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -2,341
2025-05-09 NEO / NeoGenomics, Inc. 4 TETRAULT LYNN A. Lynn Tetrault Rollover IRA P - Purchase I 8.1392 7,000
2025-05-07 NEO / NeoGenomics, Inc. 4 KANOVSKY STEPHEN M P - Purchase D 7.7811 4,000
2025-05-06 NEO / NeoGenomics, Inc. 4 Zook Anthony P. Amended and Restated Anthony P. Zook Living Trust P - Purchase I 7.8793 18,900
2025-05-05 NEO / NeoGenomics, Inc. 4 Perez David Brian Perez Joint Revocable Trust David & Karen Perez TTEE U/A Dated 12/09/2016 P - Purchase I 7.63 10,000
2025-05-05 NEO / NeoGenomics, Inc. 4 Gunn Neil P - Purchase D 7.755 4,510
2025-05-02 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott P - Purchase D 7.5052 20,000
2025-05-02 NEO / NeoGenomics, Inc. 4 Aunan Greg D M - Exercise D 5,372
2025-05-02 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 5,969
2025-05-02 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -1,454
2025-05-02 NEO / NeoGenomics, Inc. 4 Aunan Greg D F - Taxes D -1,309
2025-05-01 NEO / NeoGenomics, Inc. 4 Aunan Greg D F - Taxes D -937
2025-05-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -652
2025-02-23 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott M - Exercise D 15,535
2025-02-23 NEO / NeoGenomics, Inc. 4 Smith Christopher M M - Exercise D 57,413
2025-02-23 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 8,443
2025-02-23 NEO / NeoGenomics, Inc. 4 Harris Melody M - Exercise D 8,443
2025-02-23 NEO / NeoGenomics, Inc. 4 Olivo Alicia C M - Exercise D 8,443
2025-02-23 NEO / NeoGenomics, Inc. 4 Harris Melody F - Taxes D -2,056
2025-02-23 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -2,504
2025-02-23 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -2,472
2025-02-23 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -4,207
2025-02-23 NEO / NeoGenomics, Inc. 4 Smith Christopher M F - Taxes D -14,067
2025-01-01 NEO / NeoGenomics, Inc. 4 Harris Melody F - Taxes D -7,070
2024-12-07 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -11,746
2024-12-01 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -6,224
2024-11-15 NEO / NeoGenomics, Inc. 4 Olivo Alicia C S - Sale D 15.3575 -5,175
2024-09-01 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -1,666
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)